Seismic Therapeutic, Inc.: Seismic Therapeutic Announces Participation At Multiple Upcoming Scientific Conferences In June 2024

Seismic Therapeutics, Inc. is a machine learning immunology company that applies its proprietary IMPACT platform to discover novel therapeutics for autoimmune diseases. They will be presenting data on their two lead drug candidates, S-1117 and S-4321, at three upcoming scientific conferences. These drugs target multiple pathogenic mechanisms and utilize a PD-1 agonist to treat autoimmune diseases.